D. J. Nutt
#185,131
Most Influential Person Now
D. J. Nutt's AcademicInfluence.com Rankings
D. J. Nuttmedical Degrees
Medical
#3820
World Rank
#4337
Historical Rank
Pharmacology
#503
World Rank
#562
Historical Rank
D. J. Nuttphilosophy Degrees
Philosophy
#11877
World Rank
#16421
Historical Rank
Logic
#8684
World Rank
#10891
Historical Rank
Download Badge
Medical Philosophy
D. J. Nutt's Degrees
- PhD Psychopharmacology University of Oxford
- Masters Medicine University of Oxford
Why Is D. J. Nutt Influential?
(Suggest an Edit or Addition)D. J. Nutt's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders (2010) (470)
- Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines (2000) (388)
- Serotonin and brain function: a tale of two receptors (2017) (352)
- Ketamine effects on brain GABA and glutamate levels with 1H-MRS: relationship to ketamine-induced psychopathology (2012) (270)
- BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP (2012) (249)
- Evaluation of Severe Insomnia In The General Population: Results of a European Multinational Survey (1999) (159)
- Characterization and autoradiographical localization of non‐adrenoceptor idazoxan binding sites in the rat brain (1992) (127)
- Acute Carbon Dioxide Exposure in Healthy Adults: Evaluation of a Novel Means of Investigating the Stress Response (2004) (107)
- Opioids and anxiety (2011) (93)
- Autonomic dysregulation and the Window of Tolerance model of the effects of complex emotional trauma (2011) (90)
- Adult night terrors and paroxetine (1997) (76)
- That warm fuzzy feeling: brain serotonergic neurons and the regulation of emotion (2009) (76)
- The pharmacology of anxiety. (2010) (73)
- The role of central noradrenergic dysregulation in anxiety disorders: evidence from clinical studies (2011) (69)
- Equasy — An overlooked addiction with implications for the current debate on drug harms (2009) (67)
- Noradrenergic mechanisms in the prefrontal cortex (1997) (61)
- The effects of idazoxan and other α2‐adrenoceptor antagonists on food and water intake in the rat (1991) (59)
- Review: A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD) (2010) (58)
- Voluntary exercise alters GABAA receptor subunit and glutamic acid decarboxylase-67 gene expression in the rat forebrain (2010) (53)
- Association of Short Alleles of a VNTR of the Serotonin Transporter Gene with Anxiety Symptoms in Patients Presenting After Deliberate Self Harm (1997) (49)
- Endogenous β‐Carbolines as Clonidine‐Displacing Substances (2003) (47)
- Glutamate and cortisol—a critical confluence in PTSD? (2008) (44)
- Optimizing the pentetrazol infusion test for seizure threshold measurement (1986) (44)
- Effects of acute and chronic electroconvulsive shock on noradrenaline release in the rat hippocampus and frontal cortex (1992) (43)
- The effects and after effects of the α2-adrenoceptor antagonist idazoxan on mood, memory and attention in normal volunteers (1992) (39)
- Psychiatry’s next top model: cause for a re-think on drug models of psychosis and other psychiatric disorders (2013) (38)
- Beyond psychoanaleptics – can we improve antidepressant drug nomenclature? (2009) (36)
- d-Cycloserine and performance under different states of anxiety in healthy volunteers (2007) (35)
- Characterisation of the effects of caffeine on sleep in the rat: a potential model of sleep disruption (2009) (31)
- Performance effects of diazepam during and after prolonged administration (1986) (31)
- The feasibility of abrupt methadone‐buprenorphine transfer in British opiate addicts in an outpatient setting (1997) (28)
- Effects on sleep stages and microarchitecture of caffeine and its combination with zolpidem or trazodone in healthy volunteers (2009) (27)
- Potential novel anxiolytic drugs. (2008) (27)
- Panic and hypertension: brothers in arms through 5-HT? (2007) (26)
- Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study (2009) (26)
- Dopaminergic challenges in social anxiety disorder: evidence for dopamine D3 desensitisation following successful treatment with serotonergic antidepressants (2010) (25)
- The effects of single dose anxiolytic medication on the CO2 models of anxiety: differentiation of subjective and objective measures (2010) (25)
- Flumazenil in alcohol withdrawal: a double-blind placebo-controlled study. (1997) (24)
- Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge (2011) (24)
- The effects of drugs acting at the GABAA‐receptor/ionophore after chemical kindling with the benzodiazepine receptor ligand FG 7142 (1986) (24)
- Septal driving of hippocampal theta rhythm: Role of γ-aminobutyrate-benzodiazepine receptor complex in mediating effects of anxiolytics (1985) (23)
- Evaluation of actigraphy and automated telephoned questionnaires to assess hypnotic effects in insomnia (2004) (21)
- Autoradiographical and behavioural effects of a chronic infusion of antisense to the α2D‐adrenoceptor in the rat (1999) (20)
- Neuroendocrine and clinical effects of electroconvulsive therapy and their relationship to treatment outcome (1994) (19)
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017) (19)
- Monoamine function in anxiety and depression: Information from neuroendocrine challenge tests (1987) (19)
- Alcohol alternatives – a goal for psychopharmacology? (2006) (19)
- Flumazenil in alcohol withdrawal. (1993) (18)
- Anxiety - bridging the heart/mind divide (2010) (17)
- Discriminative stimulus produced by the imidazoline I2 site ligand, 2 -BFI (1996) (17)
- Using saccadic eye movements as objective measures of tolerance in methadone dependent individuals during the hydromorphone challenge test (2003) (16)
- Why does the world have such a `down' on antidepressants? (2008) (15)
- ADHD matures: time for practitioners to do the same? (2012) (15)
- Potentiation of barbiturate‐induced alterations in presynaptic noradrenergic function in rat frontal cortex by imidazol(in)e α2‐adrenoceptor agonists (1998) (15)
- A new human (psycho)pharmacology tool: the multiple organs coincidences counter (MOCC) (1995) (14)
- Amphetamine misuse and social phobia. (2000) (11)
- Specific anatomy, non-specific drugs: the present state of schizophrenia. 5th Biennial Winter Workshop on Schizophrenia (1990) (9)
- Dizziness produced by a potent 5HT1A receptor agonist (eptapirone) is not due to postural hypotension (2005) (8)
- Central noradrenergic responsiveness to a clonidine challenge in Generalized Anxiety Disorder: a Single Photon Emission Computed Tomography study (2012) (8)
- Evaluation of Severe Insomnia In The General Population — Implications for The Management of Insomnia: The Uk Perspective (1999) (8)
- Ending the pain of children with severe epilepsy? An audit of the impact of medical cannabis in 10 patients (2020) (8)
- Evidence that imipramine‐induced postural hypotension may be centrally mediated (1988) (8)
- Relationship Between Imidazoline2 Sites and Monoamine Oxidase (2003) (7)
- The use of saccadic eye movement measures in psychopharmacology (1995) (7)
- Demonstration of clomipramine and venlafaxine occupation at serotonin reuptake sites in man in vivo (1997) (7)
- In Vivo Estimation of Imidazoline2 Binding Site Turnover (2003) (7)
- Thyroid hormones do not alter rat brain benzodiazepine receptor function in‐vivo (1983) (5)
- Investigation of the Different Types of Opioid Receptor Involved in Electroconvulsive Shock‐induced Antinociception and Catalepsy in the Rat (1991) (5)
- P.1.a.016 GABAergic control of stress-responsive epigenetic and gene expression mechanisms in the dentate gyrus (2008) (5)
- Drug Classification: Making a hash of it? - Follow-up (2007) (5)
- The cardiovascular and subjective effects of thyrotropin releasing hormone (TRH) and a stable analogue, dimethyl proline-TRH, in healthy volunteers. (1995) (5)
- 5-HT3 receptors, nausea, and serotonin reuptake inhibition. (1997) (4)
- Behavioural and physiological effects induced by an infusion of antisense to α2D‐adrenoceptors in the rat (2000) (4)
- Does the Brain Noradrenaline Network Mediate the Effects of the CO2 Challenge? Reply to Reviewers' Comments (2003) (4)
- Drug treatment of chronic insomnia — dawn at the end of a long night? (2008) (4)
- Discriminative stimulus properties of ethoxy idazoxan (1995) (4)
- Don’t panic. A guide to tryptophan depletion with disorder-specific anxiety provocation (2016) (4)
- Improved colour blindness symptoms associated with recreational psychedelic use: Results from the Global Drug Survey 2017 (2020) (4)
- Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression (2017) (3)
- Do SSRIs prolong seizure duration during ECT? (1997) (3)
- Irritability in panic disorder: Effects of imipramine treatment (1991) (3)
- Heart rate response to standing as an index of adaptation to imipramine during treatment of panic disorder (1988) (3)
- P.6.c.008 Can personality traits elucidate the relationship between substance dependence and opioid receptor availability? (2008) (2)
- Editorial: Wine and drug evaluations: lessons on making comparisons of noninferiority (2008) (2)
- P.2.a.017 Acute deep brain stimulation in the subgenual cingulate alters REM sleep in patients with treatment resistant depression (2010) (2)
- Investigation of the Affinities of Two New b‐Carbolines for Rat Brain Imidazoline2 Receptors (2003) (2)
- P.1.e.017 Hydrocortisone induces limbic, hippocampal and limbic/paralimbic cerebral perfusion changes as measured by 3T blood oxygenation level dependent (BOLD) phMRI (2008) (2)
- P.4.e.002 The further development of a new model of GAD: no effect of 7.5% CO2 on HPA axis activation in healthy volunteers (2007) (2)
- Sleep disturbance and depression (1994) (1)
- Authors’ reply (1994) (1)
- A case of reversal of treatment-resistant depression after almost 30 years of symptoms: Case Reports. (1999) (1)
- Involvement of μ-opioid receptors in electroconvulsive shock-induced antinociception in the rat (1991) (1)
- P.361 Brain serotonin release reduced among patients with severe depression: a pet study with [11c]cimbi-36 and d-amphetamine challenge (2019) (1)
- P.4.e.003 The further development of a new model of GAD: I – the effects of single dose alprazolam and zolpidem (2007) (1)
- Benzodiazepine receptors and panic (1993) (1)
- BU98008, a Highly Selective Imidazoline1‐Receptor Ligand (2003) (1)
- P.2.c.022 A systematic review of antidepressant induced jitteriness/anxiety syndrome (2007) (1)
- Initial Evaluation of Novel Selective Ligands for Imidazoline2 Receptors in Rat Whole Brain (2003) (1)
- S.15.04 Dopaminergic challenges in social anxiety disorder (2006) (1)
- P.4.c.003 Preliminary evidence of efficacy of a CRF1 receptor antagonist in the 7.5% CO2 model of anxiety (2008) (1)
- P.4.a.018 The effects of D-cycloserine on a cognitive function task under different states of anxiety in healthy volunteers (2006) (0)
- P.4.c.006 Day 3&7 jitteriness symptoms predict poor 6 week outcome in SSRI treatment and correlate with day 7 nocturnal activity (2010) (0)
- Do selective Serotonin Reuptake Inhibitors influence seizure duration during ECT (1997) (0)
- Paroxetine-remitted panic patients on a tryptophan depletion diet have a higher change in blood pressure and heart rate in response to either flumazenil or saline infusions than when not tryptophan depleted: a regression analysis (2001) (0)
- P.0610 Dopamine D3 Receptor antagonism in alcohol dependence: A case-control functional Imaging study (2021) (0)
- circadian rhythm disorders British Association for Psychopharmacology consensus statement on evidence-based treatment of (2010) (0)
- P.4.e.006 A pooled analysis of the effects of 7.5% CO2 inhalation in healthy participants: a useful model of human anxiety? (2006) (0)
- P.3.03 A double-blind, placebo-controlled, parallel group study of the effect of Org 25935 on cognitive performance (2009) (0)
- Pharmacological Treatment of Late-Life Depression (2005) (0)
- P.1.43 The effects of C-cycloserine on a cognitive task under different states of anxiety (2007) (0)
- Hypnotic Substances and Medications (2013) (0)
- P.4.e.001 The further development of a new model of GAD: II – The effects of single dose anxiolytic medication (2007) (0)
- P.3.001 Ketamine-induced changes in anterior cingulate glutamate levels correlate with positive symptom generation (2012) (0)
- P.1.33 5-HT1A receptor activation inducesupregulation of GABAAR gene expression in neurones (2005) (0)
- JMHM Reul expression in the rat forebrain Voluntary exercise alters GABAA receptor subunit and glutamic acid decarboxylase-67 gene (2010) (0)
- P.4.e.005 The effect of acute tryptophan depletion on challenge induced anxiety in anxiety disorder patients is independent of a history of depression (2006) (0)
- Exaggerated pressor response to 35% CO2 in Irritable Bowel Syndrome (2006) (0)
- P.1.117 Serotonin and the 5HTlAreceptor in the signalling of taste: A novel human surrogate marker? (2004) (0)
- SS01.02 - Shifting schizophrenia treatment paradigms: The scope for adjunctive therapies (2008) (0)
- LSD enhances suggestibility in healthy volunteers (2014) (0)
- S-5-3 Peripheral and endocrine measures of ECT'S effects: Relation to side effects and outcome (1996) (0)
- P.4.a.019 Serotonin reuptake inhibition and dopamine receptor antagonism together buffer the blood pressure response to stress in social anxiety disorder (2006) (0)
- S.07.08 Using Positron Emission Tomography to investigate microglial activation in alcohol dependence: preliminary findings (2013) (0)
- P.609 Therapeutic mechanisms of psychedelic drugs: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression (2019) (0)
- Psychopharmacological characterisation of the successive negative contrast effect in rats (2015) (0)
- P.4.e.006 Does the inhalation of CO2 activate neurosteroids in healthy participants? A pilot study (2009) (0)
- Early results from a tryptophan depletion study in panic disorder patients treated with cognitive behavioural therapy (2004) (0)
- P.4.c.009 Dose-dependent effects of a clinically effective and non-effective dose of lorazepam on 7.5% CO2-induced anxiety (2009) (0)
- P.1.e.014 Subjective effects of acute dose of hydrocortisone in healthy volunteers (2007) (0)
- P.2.b.008 Acute tryptophan depletion increases plasma prolactin in women but not men (2007) (0)
- LSD enhances the emotional response to music (2015) (0)
- The effects of hypercapnia in healthy subjects and changes after the benzodiazepine agonist lorazepam (2005) (0)
- P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study (2021) (0)
- P.6.d.014 Endogenous opioid blockade modulates neural networks implicated in attentional and behavioural control in individuals recovering from alcohol and drug dependence (2016) (0)
- The psychopharmacology of social communication and its disorders (1993) (0)
- P.6.d.006 Effects of nicotinised and denicotinised cigarette smoking on response to 7.5% carbon dioxide anxiety challenge (2010) (0)
- Mirtazapine (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With D. J. Nutt?
D. J. Nutt is affiliated with the following schools:
